Adalimumab eases symptoms, economic burden of RA

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1415, 2003-01, pp. : 7-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adalimumab eases symptoms, economic burden of RA

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 440, 2003-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Glycaemic control eases economic burden of diabetes mellitus

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 424, 2003-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Adalimumab adds to methotrexate efficacy in RA

By  

Inpharma, Vol. 1, Iss. 1645, 2008-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Tocilizumab dominates adalimumab for severe RA

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 669, 2013-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Adolescent, adult vax against pertussis eases burden in the US

By  

Inpharma, Vol. 1, Iss. 1526, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite